New Delhi, January 24, 2025: With the Union Budget 2025 drawing near, stakeholders in the pharmaceutical and healthcare sectors are calling for a 3 per cent increase in the budget allocation to bolster the country’s healthcare infrastructure. The industry is pressing for more funding to improve public health initiatives, support research and development, and ensure the availability of affordable essential medicines across the country.
The proposed hike in funding is expected to enhance healthcare coverage, upgrade hospital facilities, and promote the domestic production of critical drugs. Experts highlight that additional investment is necessary to address ongoing challenges such as rising healthcare costs, the increasing demand for modern medical technologies, and the need to expand healthcare access, particularly in underserved rural areas.
